Case Report
Copyright ©The Author(s) 2015.
World J Clin Cases. Dec 16, 2015; 3(12): 1005-1010
Published online Dec 16, 2015. doi: 10.12998/wjcc.v3.i12.1005
Figure 1
Figure 1 Skin rash on the patient’s trunk on day 18 of the treatment with daclatasvir and asunaprevir.
Figure 2
Figure 2 Clinical course of a patient with concomitant deterioration of hepatic reserve and renal function due to combination treatment with daclatasvir and asunaprevir. HCV: Hepatitis C virus; EBV: Epstein-Barr virus.